Bibliographic Details
| Title: |
Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis. |
| Authors: |
Wang, Rongliang, Mehrjou, Babak, Dehghan‐Banian, Dorsa, Wang, Belle Yu Hsuan, Li, Qiangqiang, Deng, Shuai, Liu, Chuanhai, Zhang, Zhe, Zhu, Yanlun, Wang, Haixing, Li, Dan, Lu, Xiaomin, Cheng, Jack Chun Yiu, Ong, Michael Tim Yun, Chan, Hon Fai, Li, Gang, Chu, Paul K., Lee, Wayne Yuk Wai |
| Source: |
Arthritis & Rheumatology; Mar2025, Vol. 77 Issue 3, p283-297, 15p |
| Subject Terms: |
BONES, ARTICULAR cartilage, CONNECTIVE tissue cells, CELLULAR signal transduction, REVERSE transcriptase polymerase chain reaction, IN vivo studies, RNA, GENES, MICE, KNEE joint, GENE expression, IMMUNOHISTOCHEMISTRY, CELL culture, OSTEOARTHRITIS, ANIMAL experimentation, FLUORESCENCE in situ hybridization, WESTERN immunoblotting, BONE remodeling, PHENOTYPES, SEQUENCE analysis |
| Abstract: |
Objective: Emerging evidence suggests long noncoding RNA H19 is associated with osteoarthritis (OA) pathology. However, how H19 contributes to OA has not been reported. This study aims to investigate the biologic function of H19 in OA subchondral bone remodeling and OA progression. Methods: Clinical joint samples and OA animal models induced by surgical destabilization of the medial meniscus (DMM) were used to verify the causal relationship between osteocyte H19 and OA subchondral bone and cartilage changes. MLO‐Y4 osteocyte cells subjected to fluid shear stress were used to verify the mechanism underlying H19‐mediated mechanoresponse. Finally, the antisense oligonucleotide (ASO) against H19 was delivered to mice knee joints by magnetic metal–organic framework (MMOF) nanoparticles to develop a site‐specific delivery method for targeting osteocyte H19 for OA treatment. Results: Both clinical OA subchondral bone and wildtype mice with DMM‐induced OA exhibit aberrant higher subchondral bone mass, with more H19 mice expressing osteocytes. On the contrary, mice with osteocyte‐specific deletion of H19 are less vulnerable to DMM‐induced OA phenotype. In MLO‐Y4 cells, H19‐mediated osteocyte mechanoresponse through PI3K/AKT/GSK3 signal activation by EZH2‐induced H3K27me3 regulation on protein phosphatase 2A inhibition. Targeted inhibition of H19 (using ASO‐loaded MMOF) substantially alleviates subchondral bone remodeling and OA phenotype. Conclusion: In summary, our results provide new evidence that the elevated H19 expression in osteocytes may contribute to aberrant subchondral bone remodeling and OA progression. H19 appears to be required for the osteocyte response to mechanical stimulation, and targeting H19 represents a new promising approach for OA treatment. [ABSTRACT FROM AUTHOR] |
|
Copyright of Arthritis & Rheumatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
